Telomir Pharma surged 138.8% after hours as early lab data showed its drug Telomir-1 reversed damage in cells from a child with progeria. The treatment improved cell survival, reduced oxidative stress, and restored mitochondrial function. CEO Erez Aminov sees broader potential in aging-related diseases. Retail sentiment turned extremely bullish on Stocktwits.